Home > Social responsibility > CSR > Flutter to support Cure Leukaemia’s “The Tour 21” initiative
Flutter to support Cure Leukaemia’s “The Tour 21” initiative
Flutter will partner with the 2023, 2024 and 2025 editions of the event, each of which will seek to raise £1m (€1.1m/$1.2m) for the charity.
The Tour 21 features a team of 20 amateur cyclists aiming to complete all 21 stages of the Tour de France professional cycling race. The 2023 event will cover 3,000km and take place from 24 June to 16 July.
All funds raised are invested into the Trials Acceleration Programme (TAP) network. This covers a catchment area of over 20 million people and provides access to treatments not available through standard care.
A team of specialist research nurses and other clinical roles require funding of over £1m each year to facilitate the treatments for blood cancer.
“It is an exciting partnership that brings together our passion for sport with our commitment to ‘Do More’ to support the communities in which we operate,” Flutter’s group head of communities, Kerry McNally, said.
“Cure Leukaemia is undertaking transformational trials to help treat blood cancer patients around the world. We could not be prouder to play a role in helping them to eradicate this devastating illness.”
Cure Leukaemia’s chief executive, James McLaughlin, added: “Flutter as the headline partner of the event takes The Tour 21 to a whole new level. They will work alongside our strategic partnerships to further raise the profile of the event and the charity.
“It makes a significant difference to the event’s fundraising total and the global impact we can make.”